An international breakthrough in heart valve replacement

Providence medical breast oncologist to give a special presentation on Lobular Breast Cancer and the latest data on the development of a lobular prevention vaccine.

A medication designed to block and break down the androgen receptor, a key driver of prostate cancer growth, is being evaluated in a clinical trial at Providence Cancer Institute.

Get a behind the scenes peek into the work of a cancer research administrator as she reflects on her time at Providence Cancer Institute.

Two new trials evaluating new medications or combinations of medications for people with ovarian cancer or small cell lung cancer open at Providence Cancer Institute.

In July 2025, Providence had the honor of celebrating the 150th anniversary of Providence St. Vincent, Oregon’s first hospital.

After careful consideration, we have made the difficult decision to close our inpatient obstetric and newborn care services at Providence Seaside Hospital.

Robotic thoracic surgery is less invasive, allowing patients to recover more quickly. A Providence Cancer Institute surgeon calls it a game-changer.

Update from Oregon Chief Executive Jennifer Burrows: Learn about the most recent financial sustainability measures for Oregon.

Hands-on experience in a laboratory at Providence Cancer Institute helps undergraduate students find their career path in biomedical fields.

Learn key facts about lung cancer at a free virtual talk hosted by Providence Cancer Institute and Asian Cancer Resource & Support Services.

A new medication developed at Providence Cancer Institute is being evaluated in a clinical trial for people with advanced cancers.

A phase III clinical trial for people with HR+ HER2- breast cancer aims to extend survival and improve patients’ quality of life.

Published in Nature NPJ Genomic Medicine, Providence-led Geno4ME research program study highlights early detection, personalized prevention and prospect of improved care outcomes.

A generous gift of plush blankets helps comfort patients during their chemotherapy treatments at Providence Cancer Institute Newberg Clinic.

What surprised Molly most about cold cap therapy is that she didn’t lose her hair during treatment for breast cancer.

Providence Cancer Institute hematology expert to discuss the latest updates and research on hereditary hemochromatosis in live event.

Expert voices in immuno-oncology from inside and outside Providence gather for a day of thought-provoking discussion, discovery and collaboration.

Explore new findings in cancer immunotherapy and clinical research from Providence at ASCO 2025.

Providence Cancer Institute is enrolling patients for two new immunotherapy trials targeting muscle-invasive urothelial cancer and advanced solid tumors.

When Randy was diagnosed with small cell lung cancer, he thought it was time to get his affairs in order. But a phase I clinical trial at Providence Cancer Institute gave him more time and hope.